Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery

James M Brophy1, Gilles R Dagenais2, Luce Boyer2

  • 1McGill University Health Center, Montréal, Québec, Canada.

Insights

High-sensitivity cardiac troponin T (hs-cTnT) levels are stable in patients with and without coronary artery disease over time. However, diabetes, renal function, and C-reactive protein influence hs-cTnT values, requiring careful interpretation.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Chemistry

Background:

  • High-sensitivity cardiac troponin T (hs-cTnT) is crucial for diagnosing acute myocardial infarction.
  • Interpretation often relies on the 99th percentile threshold (14 ng/L) of normal populations.
  • The variability of hs-cTnT in stable patients with or without coronary artery disease (CAD) remains largely unknown.

Purpose of the Study:

  • To investigate the short- and long-term variability of hs-cTnT.
  • To assess hs-cTnT levels in stable patients with CAD and controls without CAD.
  • To identify predictors of elevated hs-cTnT values.

Main Methods:

  • A prospective cohort study involving 75 stable patients with CAD and 25 controls without CAD.
  • Each participant provided 15 hs-cTnT measurements over a one-year period.
  • Patients with CAD were categorized into stable angina, remote myocardial infarction, or repetitive acute coronary syndrome groups.

Main Results:

  • Individual hs-cTnT measurements showed no significant variation across different time windows (within-day to yearly).
  • The repetitive acute coronary syndrome group exhibited the highest median hs-cTnT (6.3 ng/L) and variability (IQR 6.9 ng/L).
  • Diabetes, impaired renal function, and elevated C-reactive protein independently predicted higher hs-cTnT values, with the 99th percentile reaching 39 ng/L in CAD patients.

Conclusions:

  • Individual hs-cTnT readings are stable over extended periods in both CAD and non-CAD patients.
  • Diabetes, renal dysfunction, and elevated C-reactive protein are key predictors of higher hs-cTnT, potentially exceeding conventional diagnostic thresholds.
  • Clinical context is essential for accurate hs-cTnT interpretation due to influencing factors.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
740
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
675
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
241
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
498
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
319